crohn's disease and glp-1 Gut Hormones Inflammatory Bowel What to Know About Creeping
Description
A new federal multidistrict litigation docket has been established to centralize lawsuits alleging that glucagonlike peptide1 (GLP1) receptor agonist drugs, including Ozempic, Wegovy, Rybelsus, Mounjaro, and others, caused serious vision loss linked to nonarteritic anterior ischemic optic neuropathy (NAION)
As demand increased, several challenges followed
Of these patients, 1,284 met the inclusion criteria, 128 actively used a GLP-1RA, and 1,156 were not using a GLP-1RA
The medical goal is bigger than a number
